Bright Minds Biosciences is offering a new clinical trial opportunity for Adults with PWS, with sites in Melbourne and Sydney. The Phase 2 clinical trial will evaluate a new oral medication as a possible treatment for hyperphagia and the behavioural/neuropsychiatric symptoms of PWS. This randomized, double-blind, placebo-controlled study will assess the drug’s efficacy, safety, and tolerability in adult PWS patients. For more information